EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Cancer immunology, immunotherapy : CII

Laheurte C

Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.

2022

Clinics and research in hepatology and gastroenterology

Neuzillet C

Correlation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: analysis of aggregated data from a systematic literature review.

2022

The oncologist

Thouvenin J

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

2022

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Retif P

Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT.

2022

Cancer

Colonna M

Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites.

2022

Frontiers in oncology

Langlois B

LRP-1-dependent control of calpain expression and activity: A new mechanism regulating thyroid carcinoma cell adhesion.

2022

Cancers

Legrand T

Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial.

2022

The Lancet. Oncology

Westeel V

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.

2022

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Pâris P

Diffusion-weighted and gadolinium-enhanced dynamic MRI in parotid gland tumors.

2022

Acta oncologica (Stockholm, Sweden)

Hennemann A

Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.